Pharmaceutical prescription – central government governance and supervision (RiR 2023:23)
Today, the central government and the regions have limited possibilities to prevent the prescription of medicinal products to the wrong people or for the wrong purpose. This puts patients in danger and entails substantial costs to society. The Swedish National Audit Office calls on the Government to improve supervision.
Share in social media and by e-mail
Send your questions or comments via the form below and we will make sure that they reach the right member of staff. Please state if your question concerns the information on this particular page.